Evaluation of Hematological, Coagulation and Inflammatory Parameters in COVID- 19 in a Tertiary Care Setting of Sindh, Pakistan
DOI:
https://doi.org/10.51985/JBUMDC2022086Keywords:
COVID-19, hematological parameters, neutrophil to lymphocyte ratio.Abstract
Objective: COVID-19 is caused by SARS-CoV-2. Although pulmonary manifestations have been identified as the major
symptoms, several hematological abnormalities play a vital role in disease treatment and monitoring. This study summarizes
the hematological abnormalities (platelets, white blood cells, hemoglobin, coagulation alterations) as well as changes in
inflammatory markers.
Study Design And Setting: A retrospective cross-sectional study was conducted among PCR positive COVID-19 patients.
The study was conducted at pathology department of CMH Malir between Aug 2021 and Jan 2022.
Methodology: All the individuals with positive real-time reverse transcription-polymerase chain reaction (PCR) results
were involved in the study. One hundred and twenty six COVID-19 patients were included using convenience sampling.
Six ml venous blood was collected and analyzed. The data were entered and analyzed using SPSS version 23.
Results: Among 126 patients different hematological and inflammatory parameters were noted. Significantly raised CRP,
ESR in 96.8% and 92.9 % were noted respectively. Other parameters like raised D-dimers was found in 60.3 %, leukocytosis
65.1%, neutrophilia in 62.7 %. Significantly elevated neutrophil lymphocyte ratio was seen in 62 % of patients. Parameters
like anemia and prolonged PT / APTT were not significant.
Conclusion: The study concluded that CRP, ESR, leukocytosis, neutrophilia, elevated Neutrophil to lymphocyte ratio and
D-dimers are significantly raised among serious patients with COVID-19 disease and can be used as monitoring, prognosis
and severity index.
References
Firas A, Rabi MSAZ, Kasasbeh GA, Salameh DM, Amjad
DA-N. SARS-CoV-2 and coronavirus disease 2019: what we
know so far. Pathogens.2020 ; 9(3):231.DOI:http:// doi.org/
3390/pathogens9030231.
Fan BE, Ching VCL, Chan SSW, et al. Hematologic parameters
in patients with COVID-19 infection. Am J Hematol.2020;
(6): E131–E134. DOI:http:// doi.org/10.1002/ajh.25774.
Mathieu E, Ritchie H, Guirao LR, Appel C, Gavrilov D,
Giattino C et al. Coronavirus Pandemic (COVID-19). Published
online at Our World in Data. Retrieved 2021-11-14.
Pakistan Cases Details - COVID-19 Health Advisory Platform
Vetter P, Vu DL, L Huillier AG, Schibler M, Kaiser L,
Jacquerioz F. Clinical features of covid-19.BMJ.
;369:m1470. DOI:http:// doi.org/10.1136/ bmj.m1470.
Hellewell J, Abbott S, Gimma A, et al. Feasibility of controlling
COVID-19 outbreaks by isolation of cases and contacts.
Lancet Glob Health.2020;8(4):e488-e496. DOI:http://
doi.org/10.1016/S2214-109X(20)30074-7.
Fan BE Chong VCL, Chann SSW ,et al. Hematological
parameters in patients with covid 19 infection. Am J
Hematol.2020;95(11):1442. DOI:http:// doi.org/10.1002/
ajh.25774
Sharif F, Khan S, Junaid A, Jahangir S, Saeed M, Ijaz M, et
al. Early hematological indicators of severe covid 19 disease
in hospitalized patients. Data from South Asian population.
Int J Lab Hematol.2021;43(5):1237-1242. DOI:http://
doi.org/10.1111/ijlh.13533
Bellmann-Weiler R, Lanser L, Barket R, Rangger L, Schapfl
A, Schaber M, et al. Prevalence and Predictive Value of
Anemia and Dysregulated Iron Homeostasis in Patients with
COVID-19 Infection. J Clin Med. 2020 ;9(8):2429. DOI:http://
doi.org/10.3390/jcm9082429.
Tao Z, Xu J, Chen W, Yang Z, Xu X, Liu L, et al. Anemia is
associated with severe illness in COVID-19: A retrospective
cohort study. J Med Virol. 2021;93(3):1478-1488. DOI:http://
doi.org/10.1002/jmv.26444.
Centers for Disease Control and Prevention. Interim clinical
guidance for management of patients with confirmed
Coronavirus Disease (COVID-19) 2020.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al.
Clinical characteristics of coronavirus disease 2019 in China.
N Engl J Med. 2020; 382:1708–1720. DOI:http://
doi.org/10.1056/NEJMoa2002032.
Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al.
Dysregulation of immune response in patients with COVID-
in Wuhan, China. Clin Infect Dis. 2020;71 (15):762–768.
DOI:http:// doi.org/10.1093/cid/ciaa248.
Gong J, Ou J, Qiu X, Jie Y, Chen Y, Yuan L, et al. A Tool for
Early Prediction of Severe Coronavirus Disease 2019 (COVID-
: A Multicenter Study Using the Risk Nomogram in Wuhan
and Guangdong, China. Clin Infect Dis. 2020;71(15):833-
DOI:http:// doi.org/10.1093/cid/ciaa443.
Li Q, Cao Y, Chen L, Wu D, Yu J, Wang H, et al. Hematological
features of persons with COVID-19. Leukemia.
;34(8):2163–2172. DOI:http:// doi.org/10.1038/s41375-
-0910-1.
Zhang B, Zhou X, Qiu Y, Song Y, Feng F, Feng J, Wang J,
et al. Clinical characteristics of 82 cases of death from COVID-
PLoS One. 2020;15(7): e0235458. DOI:http://
doi.org/10.1371/journal.pone.0235458.
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et
al. A pneumonia outbreak associated with a new coronavirus
of probable bat origin. Nature. 2020;579(7798):270-273.
DOI:http:// doi.org/10.1038/s41586-020-2012-7.
Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and
predictive role of NLR, d-NLR and PLR in COVID-19
patients. Int Immunopharmacol. 2020; 84: 106504. DOI:http://
doi.org/10.1016/j.intimp.2020.106504.
Agustí C, Rañó A, Rovira M, Filella X, Benito N, Moreno
A, et al. A. Inflammatory response associated with pulmonary
complications in non-HIV immunocompromised patients.
Thorax. 2004 ;59(12):1081-8. DOI:http:// doi.org/10.1136/
thx.2004.030551.
Marnell L, Mold C, Du Clos TW. C-reactive protein: ligands,
receptors and role in inflammation. Clin Immunol. 2005;
(2):104-11.DOI:http:// doi.org/10.1016/j.clim. 2005.08.004.
Gavriatopoulou M, Korompoki E, Fotiou D, NtanasisStathopoulos I, Psaltopoulou T, Kastritis E, et al. Organspecific manifestations of COVID-19 infection. Clin Exp
Med. 2020 ;20(4):493-506. DOI:http:// doi.org/10.1007/
s10238-020-00648-x.
Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al.
The origin, transmission and clinical therapies on coronavirus
disease 2019 (COVID-19) outbreak - an update on the status.
Mil Med Res. 2020 ;7(1):11. DOI:http:// doi.org/10.1186/
s40779-020-00240-0.
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical
characteristics of 99 cases of 2019 novel coronavirus
pneumonia in Wuhan, China: a descriptive study. Lancet.
;395:507-513.DOI;http//doi.org/10.1016/S0140-
(20)30211-7.
Maquet J, Lafaurie M, Sommet A et al. Thrombocytopenia
is independently associated with poor outcome in patients
hospitalized for COVID-19. British Journal of Haematology.
; 10. DOI;http//doi.org/1111/bjh.16950
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Faiz us Saba, Zunera Sajjad, Ayesha Khan, Muhammad Iqbal, Muhammad Faisal Faheem, Nabeela Khan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
